These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20536098)

  • 1. [Imiquimod cream. A cream to use with precaution].
    Taeron C
    Rev Infirm; 2010 Jun; (161):47-9. PubMed ID: 20536098
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond a decade of 5% imiquimod topical therapy.
    A Gaspari A; Tyring SK; Rosen T
    J Drugs Dermatol; 2009 May; 8(5):467-74. PubMed ID: 19537370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imiquimod in dermatology: an overview.
    Hanna E; Abadi R; Abbas O
    Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New perspective in immunotherapy: local imiquimod treatment].
    Kemény L; Nagy N
    Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
    Akkilic-Materna M; Massone C; Komericki P
    Acta Derm Venereol; 2011 Jun; 91(4):432-5. PubMed ID: 21547348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Photodynamic therapy vs imiquimod].
    Serra-Guillén C; Nagore E; Guillén C
    Actas Dermosifiliogr; 2012; 103(6):488-501. PubMed ID: 22178262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.
    Wagstaff AJ; Perry CM
    Drugs; 2007; 67(15):2187-210. PubMed ID: 17927284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod induces sustained remission of actinic damage: a case report spanning one decade of observation.
    Knackstedt TJ; Quitadamo M
    Cutis; 2015 Feb; 95(2):E20-3. PubMed ID: 25750973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions.
    Cannon PS; O'Donnell B; Huilgol SC; Selva D
    Br J Ophthalmol; 2011 Dec; 95(12):1682-5. PubMed ID: 20702431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating skin cancer with topical cream.
    Micali G; Lacarrubba F; Dinotta F; Massimino D; Nasca MR
    Expert Opin Pharmacother; 2010 Jun; 11(9):1515-27. PubMed ID: 20408746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNalpha-2b and topical imiquimod 5% cream.
    Turan A; Saricaoglu H; Baskan EB; Toker SC; Tunali S
    Int J Dermatol; 2009 Feb; 48(2):214-5. PubMed ID: 19200213
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient Perception of Imiquimod Treatment for Actinic Keratosis and Superficial Basal Cell Carcinoma in 202 Patients.
    Waalboer-Spuij R; Holterhues C; van Hattem S; Schuttelaar ML; Gaastra MT; Kuijpers DI; Hollestein LM; Nijsten TE
    Dermatology; 2015; 231(1):56-62. PubMed ID: 25925162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical treatment of basal cell carcinoma with the immune response modifier imiquimod.
    Papakostas D; Stockfleth E
    Future Oncol; 2015 Nov; 11(22):2985-90. PubMed ID: 26450707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod 5 percent cream and the treatment of cutaneous malignancy.
    Navi D; Huntley A
    Dermatol Online J; 2004 Jul; 10(1):4. PubMed ID: 15347486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
    Shulstad RM
    Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of imiquimod in the treatment of periocular tumours.
    Ross AH; Kennedy CT; Collins C; Harrad RA
    Orbit; 2010 Apr; 29(2):83-7. PubMed ID: 20394545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapeutic options for actinic keratosis and basal cell carcinoma.
    Sligh JE
    Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S76-80. PubMed ID: 25268601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation and efficacy of Imiquimod 3.75% cream for the treatment of actinic keratosis, pigmented basal cell carcinomas, and actinic cheilitis.
    Paolino G; Cantoresi F; Mercuri SR; Cantisani C
    Dermatol Ther; 2020 May; 33(3):e13356. PubMed ID: 32239714
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple basal cell carcinomas after radiation treatment: successful treatment with topical imiquimod.
    Santiago Sánchez-Mateos D; Goiriz Valdés R; Daudén Tello E
    Clin Exp Dermatol; 2010 Mar; 35(2):199-200. PubMed ID: 19486047
    [No Abstract]   [Full Text] [Related]  

  • 20. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
    Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M
    Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.